A six‐year audit of clinical outcomes following the treatment of suction termination of pregnancy‐retained products of conception symptoms with 200 µg of misoprostol orally or sublingually three times a day for six doses showed that it was 93% effective and it reduced the repeat dilation and curettage rate by 79.6% (P < 0.001).